GWLL
Goldenwell Biotech, Inc.Company with tickers: GWLL
CIK
1800373
Shares Outstanding
99,000,000
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | $0 | USD | 2025-09-30 | 10-Q | 2025-12-08 |
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | $0 | USD | 2025-09-30 | 10-Q | 2025-12-08 |
| Gross Profit | $25,000 | USD | 2025-09-30 | 10-Q | 2025-12-08 |
| Operating Expenses | $30,885 | USD | 2025-09-30 | 10-Q | 2025-12-08 |
| Research & Development | — | ||||
| Operating Income | $-5,885 | USD | 2025-09-30 | 10-Q | 2025-12-08 |
| Net Income | $-7,985 | USD | 2025-09-30 | 10-Q | 2025-12-08 |
| EPS (Basic) | — | ||||
| EPS (Diluted) | — |